Alzheimer´s drug Leqembi has full FDA approvalby News Wires July 7, 2023WASHINGTON - US officials granted full approval to a closely watched Alzheimer´s drug, clearing the way for Medicare and other ...
Alzheimer’s drug reduces cognitive declineby News Wires May 5, 2023CHICAGO - An experimental Alzheimer's drug developed by Eli Lilly and Co slowed cognitive decline by 35 per cent in ...
Alzheimer’s drug cited as Medicare premium jumps by $21.60by News Wires November 13, 2021WASHINGTON — Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ...